etoposide has been researched along with Neoplasms, Nervous System in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canepa, E; Colla, R; De Ciucis, CG; Domenicotti, C; Furfaro, AL; Marengo, B; Marinari, UM; Pronzato, MA; Ricciarelli, R; Traverso, N | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Ehrlich, L; Goldberg, GL; Jones, JG; O'Hanlan, KA; Rodriguez-Rodriguez, L; Runowicz, CD | 1 |
| Alvarado, CS; Buchanan, GR; Kim, TH; Ragab, AH; Sartain, P; Zaatari, G | 1 |
1 review(s) available for etoposide and Neoplasms, Nervous System
| Article | Year |
|---|---|
Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature.
Topics: Adult; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Middle Aged; Nervous System Neoplasms; Uterine Cervical Neoplasms | 1991 |
1 trial(s) available for etoposide and Neoplasms, Nervous System
| Article | Year |
|---|---|
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
2 other study(ies) available for etoposide and Neoplasms, Nervous System
| Article | Year |
|---|---|
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Neoplasm Staging; Nervous System Neoplasms; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction | 2013 |
Use of VP-16-213 in the treatment of familial erythrophagocytic lymphohistiocytosis.
Topics: Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Lymphatic Diseases; Male; Nervous System Neoplasms; Podophyllotoxin | 1986 |